Zhu Z, Rosenkranz KA, Kusunoki Y, Li C, et al. Finerenone Added to RAS/SGLT2 Blockade for Chronic Kidney Disease in Alport Syndrome. Results of a Randomized Controlled Trial with Col4a3-/- Mice. J Am Soc Nephrol 2023 Jul 10. doi: 10.1681/ASN.0000000000000186.
PMID: 37428955